Literature DB >> 4027202

Risks of midtrimester amniocentesis; assessment in 3000 pregnancies.

N J Leschot, M Verjaal, P E Treffers.   

Abstract

The obstetric outcome of 3000 pregnancies with midtrimester amniocentesis was followed in all but one patient. Thirty pregnancies ended in fetal death or abortion within 3 weeks after amniocentesis. Chronologically 23 of these occurred in the first series of 1500 pregnancies and the remaining seven fetal deaths/abortions within 3 weeks after amniocentesis occurred in the second series of 1500 pregnancies. Fetal loss within 3 weeks after amniocentesis was apparently related to the experience of the obstetrician and to the use of modern ultrasound guidance. It is concluded that the risk of fetal death after midtrimester amniocentesis is approximately 0.5%, if only experienced obstetricians using modern techniques are involved.

Entities:  

Mesh:

Year:  1985        PMID: 4027202     DOI: 10.1111/j.1471-0528.1985.tb03049.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  8 in total

1.  Prenatal diagnosis by amniocentesis and chorionic villus biopsy.

Authors:  J L Reynolds
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

Review 2.  Prenatal diagnosis of common genetic disorders.

Authors:  M D Crawfurd
Journal:  BMJ       Date:  1988 Aug 20-27

3.  Screening for Down's syndrome.

Authors:  I R McFadyen
Journal:  BMJ       Date:  1988-11-19

4.  Influence of anchoring on miscarriage risk perception associated with amniocentesis.

Authors:  Regina Nuccio; S Shahrukh Hashmi; Joan Mastrobattista; Sarah Jane Noblin; Jerrie Refuerzo; Janice L Smith; Claire N Singletary
Journal:  J Genet Couns       Date:  2014-09-17       Impact factor: 2.537

5.  Amniotic fluid and amniotic membrane stem cells: marker discovery.

Authors:  Maria G Roubelakis; Ourania Trohatou; Nicholas P Anagnou
Journal:  Stem Cells Int       Date:  2012-06-03       Impact factor: 5.443

6.  In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.

Authors:  Maria G Roubelakis; Vasiliki Bitsika; Dimitra Zagoura; Ourania Trohatou; Kalliopi I Pappa; Manousos Makridakis; Aristidis Antsaklis; Antonia Vlahou; Nicholas P Anagnou
Journal:  J Cell Mol Med       Date:  2011-09       Impact factor: 5.310

7.  Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.

Authors:  Maria G Roubelakis; Grigorios Tsaknakis; Kalliopi I Pappa; Nicholas P Anagnou; Suzanne M Watt
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  Ductus Venosus Doppler Flow Velocity after Transplacental and Non-transplacental Amniocentesis during Midtrimester.

Authors:  Burcu Artunc Ulkumen; Halil Gursoy Pala; Yesim Bulbul Baytur; Faik Mumtaz Koyuncu
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.